155 related articles for article (PubMed ID: 27019866)
21. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings.
Blennow K; Zetterberg H
Prog Mol Biol Transl Sci; 2019; 168():3-23. PubMed ID: 31699324
[TBL] [Abstract][Full Text] [Related]
22. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
[TBL] [Abstract][Full Text] [Related]
23. Validation of the AD-CSF-index in autopsy-confirmed Alzheimer's disease patients and healthy controls.
Struyfs H; Molinuevo JL; Martin JJ; De Deyn PP; Engelborghs S
J Alzheimers Dis; 2014; 41(3):903-9. PubMed ID: 24705548
[TBL] [Abstract][Full Text] [Related]
24. Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies.
Poorbaugh J; Samanta T; Bright SW; Sissons SE; Chang CY; Oberoi P; MacDonald AJ; Martin AP; Cox KL; Benschop RJ
J Immunol Methods; 2019 Mar; 466():9-16. PubMed ID: 30590020
[TBL] [Abstract][Full Text] [Related]
25. Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.
Meng X; Li T; Wang X; Lv X; Sun Z; Zhang J; Su F; Kang S; Kim S; An SSA; Yu X; Zhang C; Wang H
Alzheimers Res Ther; 2019 Oct; 11(1):89. PubMed ID: 31651358
[TBL] [Abstract][Full Text] [Related]
26. Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.
Lövheim H; Elgh F; Johansson A; Zetterberg H; Blennow K; Hallmans G; Eriksson S
Alzheimers Dement; 2017 Jul; 13(7):778-782. PubMed ID: 28073031
[TBL] [Abstract][Full Text] [Related]
27. Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19.
Bhatraju PK; Morrell ED; O'Connor NG; Choi A; Fitzpatrick M; Smith CH; Wurfel MM; Liles WC
Biomark Med; 2023 May; 17(9):459-464. PubMed ID: 37650680
[No Abstract] [Full Text] [Related]
28. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
[TBL] [Abstract][Full Text] [Related]
30. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
Robinson RA; Amin B; Guest PC
Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
[TBL] [Abstract][Full Text] [Related]
31. Blood and plasma-based proteomic biomarker research in Alzheimer's disease.
Lista S; Faltraco F; Prvulovic D; Hampel H
Prog Neurobiol; 2013; 101-102():1-17. PubMed ID: 22743552
[TBL] [Abstract][Full Text] [Related]
32. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
[TBL] [Abstract][Full Text] [Related]
33. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
Hampel H; Lista S; Khachaturian ZS
Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
[TBL] [Abstract][Full Text] [Related]
34. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
Doecke JD; Rembach A; Villemagne VL; Varghese S; Rainey-Smith S; Sarros S; Evered LA; Fowler CJ; Pertile KK; Rumble RL; Trounson B; Taddei K; Laws SM; Macaulay SL; Bush AI; Ellis KA; Martins R; Ames D; Silbert B; Vanderstichele H; Masters CL; Darby DG; Li QX; Collins S;
J Alzheimers Dis; 2018; 61(1):169-183. PubMed ID: 29171991
[TBL] [Abstract][Full Text] [Related]
35. Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer's Disease.
Wu YY; Hsu JL; Wang HC; Wu SJ; Hong CJ; Cheng IH
Dement Geriatr Cogn Dis Extra; 2015; 5(3):424-34. PubMed ID: 26675645
[TBL] [Abstract][Full Text] [Related]
36. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.
Bittner T; Zetterberg H; Teunissen CE; Ostlund RE; Militello M; Andreasson U; Hubeek I; Gibson D; Chu DC; Eichenlaub U; Heiss P; Kobold U; Leinenbach A; Madin K; Manuilova E; Rabe C; Blennow K
Alzheimers Dement; 2016 May; 12(5):517-26. PubMed ID: 26555316
[TBL] [Abstract][Full Text] [Related]
37. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
[TBL] [Abstract][Full Text] [Related]
38. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.
Zhu Y; Chai YL; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CP; Lai MK
Alzheimers Dement (Amst); 2017; 7():41-47. PubMed ID: 28239640
[TBL] [Abstract][Full Text] [Related]
39. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
Goldknopf IL; Park HR; Sabbagh M
Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
